First Trust NYSE Arca Biotechnology Index Fund
199 hedge funds and large institutions have $677M invested in First Trust NYSE Arca Biotechnology Index Fund in 2020 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 61 increasing their positions, 64 reducing their positions, and 35 closing their positions.
347% more call options, than puts
Call options by funds: $1.35M | Put options by funds: $302K
1.62% more ownership
Funds ownership: 45.54% → 47.16% (+1.6%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
5% less repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 64
5% less funds holding
Funds holding: 210 → 199 (-11)
17% less capital invested
Capital invested by funds: $818M → $677M (-$141M)
20% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 35
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVH
Psagot Value Holdings
Tel Aviv,
Israel
|
+$14.5M |
| 2 |
TI
tru Independence
Portland,
Oregon
|
+$14M |
| 3 |
AIC
Ameritas Investment Company
Lincoln,
Nebraska
|
+$5.11M |
| 4 |
LPL Financial
San Diego,
California
|
+$4.88M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.14M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$22.2M |
| 2 |
Millennium Management
New York
|
-$18.2M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$16.9M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$10.4M |
| 5 |
HSBC Holdings
London,
United Kingdom
|
-$4.79M |
FBT Hedge Fund Activity: Q1 2020 in Review
199 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q1 2020, worth a combined $677M — down 17% from $818M a quarter earlier.
Sellers outnumbered buyers: 35 funds closed out of FBT and 28 opened new positions — a net loss of 7 holders — while 64 trimmed existing stakes and 61 added.
The largest buyer was Psagot Value Holdings, opening a new position worth an estimated $14.5M. The largest seller was Bank of America, cutting an estimated $22.2M.
- 199 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q1 2020, down from 210 in Q4 2019.
- Funds reported $677M of First Trust NYSE Arca Biotechnology Index Fund stock for Q1 2020, down 17% quarter-over-quarter.
- 28 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q1 2020 and 35 closed out, a net change of -7 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q1 2020 was Psagot Value Holdings, an estimated $14.5M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q1 2020 was Bank of America, an estimated $22.2M sold.
Based on aggregated 13F filings for Q1 2020.